Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Sjogren’s syndrome
•
Neurology
•
Neuro-immunology
What is your initial treatment paradigm for someone with both CNS and peripheral neurologic Sjogren’s?
Related Questions
How would you treat chorea in a patient with Sjögren’s syndrome and positive beta 2 glycoprotein I antibodies?
Do you consider immunosuppression in patients with a history of Sjogren's disease and clinical features of inclusion body myositis?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
What is your workup and treatment approach for cranial neuropathies in patients with lupus?
What is your treatment approach to neuropsychiatric symptoms secondary to lupus?
How do you mitigate the risk of rebound disease activity when discontinuing S1p inhibitors or Tysabri in patients with multiple sclerosis?
Would you consider anti-CD20 agents for treatment of multiple sclerosis in patients with history of breast cancer?
What is your approach to immune management in opsoclonus-myoclonus-ataxia syndrome?
Is there any role for immunosuppressive therapy in patients with primary Sjogren's disease with severe pulmonary artery hypertension without ILD findings?
In a patient with sicca symptoms and SS-B antibodies only, can a minor salivary gland lip biopsy with lymphoid aggregates, but also scattered areas of acute neutrophilic inflammation be consistent with Sjogren's Disease?
